Enbrel 25 mg/0.5 mL single-dose vial Images
Generic Name: etanercept
This medication has been identified as Enbrel 25 mg/0.5 mL single-dose vial. It is supplied by Amgen Inc.
Enbrel is used in the treatment of Ankylosing Spondylitis; Rheumatoid Arthritis; Psoriatic Arthritis; Juvenile Rheumatoid Arthritis; Plaque Psoriasis and belongs to the drug classes antirheumatics, TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Enbrel 25 mg/0.5 mL single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Enbrel
- Generic Name
- etanercept
- Strength
- 25 mg/0.5 mL single-dose vial
- Availability
- Prescription only
- Drug Class
- Antirheumatics, TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- Manufacturer
- Immunex Corporation
- National Drug Code (NDC)
- 58406-0055
See also:
More about Enbrel (etanercept)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (306)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.